82
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
368139
SLBST Pharma develops robust therapeutic platform for treatment of endometriosis.
Mark Connell: Co-Founder, President and COOPast Role: nuBound, Founder & CEO
About the Company
SLBST Pharma develops robust therapeutic platform for treatment of endometriosis.
SLBST is the holder of method-of-treatment patents for the "use of HCQ in an amount appropriate to treat endometriosis" in the US and Europe. On its successful pre-clinical prospects, the company plans to pursue both composition-of-matter and
method-of-treatment patent claims.
The company was founded in 2016 and is based in Tampa, Florida.
